跳至主要内容
临床试验/NCT02818985
NCT02818985已完成2 期

Intra-articular Dexamethasone vs Intra-articular Dexamedetomidine

Assiut University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
60
试验地点
1
主要终点
pain free time

研究概览

简要总结

Pain relief in knee Arthroscopic Surgery is essential for rapid recovery of function.

详细描述

Intra-articular analgesia is useful in reducing patients' postoperative disability. It anticipates and prevents the onset of pain, and helps avoid the need for additional drugs. Usually it is possible to reach good analgesia in the immediate postoperative period by the administration of analgesic drugs. Recently, intra-articular administration of different anaesthetic substances with a local action (e.g. bupivacaine) has been introduced in clinical practice. The aim of the administration of these substances should not be the reduction of postoperative pain, but its prevention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled for knee arthroscopy under spinal anaesthesia

排除标准

  • Diabetes Mellitus
  • Contraindication to spinal anesthesia
  • Patient refusal

研究组 & 干预措施

Dexamethasone

Active Comparator

patients will receive intra-articular 8 mg dexamethasone added to 18 mL 0.25% bupivacaine into the knee joint.

干预措施: Dexamethasone (Drug)

Dexmedetomidine

Active Comparator

patients will receive intra-articular 1ug/kg dexmedetomidine added to 18 mL 0.25% bupivacaine into the knee joint.

干预措施: Dexmedetomidine (Drug)

Control

Placebo Comparator

patients will receive intra-articular 18 mL 0.25% bupivacaine and 2mL isotonic saline into the knee joint.

干预措施: Saline (Drug)

结局指标

主要结局

pain free time

时间窗: 48 hours

VAS

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Seham Mohamed Moeen Ibrahim

MD

Assiut University

研究点 (1)

Loading locations...

相似试验